Latest news items
Januari 11, 2012
KeyGene reaches important milestones in its KeyPoint Mutation Breeding program
KeyGene® has invested successfully in novel approaches to create targeted mutations in specific genes, in order to generate plant material that can directly enter commercial breeding programs. KeyPoint® MB (Mutation Breeding) is designed to help breeders optimally exploit the strengths of random mutagenesis. Using newly developed techniques, KeyPoint MB singles out individual carriers of specific point mutations, amongst thousands of mutagenized seedlings. Starting from any (elite) line, KeyPoint MB delivers new alleles in a few months, for immediate use as breeding or production material.
September 12, 2011
KeyGene and Wageningen UR launch new R&D facility for next generation high throughput DNA sequencing
Today Wageningen UR (University & Research centre) and KeyGene announce the start of a joint DNA sequencing facility with so-called second and third generation DNA sequencers with accompanying ICT and bio-informatics infrastructure. The facility is founded thanks to a 1.7 million Euro investment with the financial support of the CAT-AgroFood of Wageningen UR, an initiative of the Dutch government (ministry of Economic Affairs, Agriculture & Innovation), the Province of Gelderland and Wageningen UR. The facility will be accessible to other parties, such as breeding companies, universities and hospitals and will belong to the top DNA research facilities in Europe.
September 1, 2011
Lantmännen SW Seed and KeyGene to collaborate on molecular breeding of Field Crops
Lantmännen SW Seed, an international plant breeding company with its head office in Svalöv, South Sweden, has recently signed a service agreement with KeyGene, a technology based company from the Netherlands, to accelerate their Oilseed rape and wheat breeding programs to meet the requirements of the future market. This will especially benefit the winter oilseed program within SW Winter Oilseed AB.
June 14, 2011
NCGR and KeyGene in agreement to boost genome sequence assemblies.
Today, the NCGR Sequencing Center and KeyGene announced they have entered into a non-exclusive licensing agreement that will enable NCGR to market and execute sequence-based physical mapping projects using the proprietary KeyGene® Whole Genome Profiling (WGPTM) technology.
For more news items, visit the news archive.